Abstract
Recent genomic analyses of metastatic prostate cancer have provided important insight into adaptive changes in androgen receptor (AR) signaling that underpin resistance to androgen deprivation therapies. Novel strategies are required to circumvent these AR-mediated resistance mechanisms and thereby improve prostate cancer survival. In this review, we present a summary of AR structure and function and discuss mechanisms of AR-mediated therapy resistance that represent important areas of focus for the development of new therapies.
| Original language | English |
|---|---|
| Article number | a030478 |
| Journal | Cold Spring Harbor Perspectives in Medicine |
| Volume | 8 |
| Issue number | 12 |
| Early online date | 12 Mar 2018 |
| DOIs | |
| Publication status | Published - 3 Dec 2018 |
| Externally published | Yes |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- prostate cancer
- Androgen Receptor
Fingerprint
Dive into the research topics of 'New Opportunities for Targeting the Androgen Receptor in Prostate Cancer'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver